The guidance, along with comments from FDA Commissioner Marty Makary, adds to existing policy that classifies low-risk ...
The Naox Link in-ear EEG platform is the first of its kind to be cleared for prescription use at home or in healthcare ...
Federal action underscores growing distinction between whole-leaf botanical supplements and synthetic derivatives ...
A prospective study of 39 mother-infant dyads exposed to SARS-CoV-2 during pregnancy suggested that cognitive skills in ...
Salon workers have pushed for a ban on the chemical, which increases the risk of hormone-related cancers, since 2021.
"There is no safe level of exposure in consumer products that are heated and inhaled, particularly in occupational settings ...
The FDA will ease regulation of digital health products, aiming to deregulate AI and promote its widespread use.
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...
The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...
FDA nonmedical wearable health data devices providing general health info will not face regulation, clarifying guidance for tech companies and investors.
BrainSpace, a medtech focused on neurological injuries and illnesses, received 501 (k) clearance from the FDA for its brain ...
Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback